Pathophysiology of Type 2 Diabetes Mellitus

  • A. J. Scheen
  • P. J. Lefèbvre
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 119)

Abstract

Non-insulin-dependent diabetes mellitus (NIDDM), also called type 2 diabetes mellitus, is a common metabolic disorder that afflicts 2%–5% of the adult population of most Western countries, with, however, wide international variation (King et al. 1993). Furthermore, NIDDM is often undiagnosed even in the Western countries (Hortulanus-Beck et al. 1990), and numerous data indicate that undiagnosed NIDDM is not a benign condition (Harris 1993). Certainly, NIDDM is a leading cause of disability and death in developed and developing nations (Songer 1992).

Keywords

Toxicity Magnesium Carbohydrate Lactate Tyrosine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O (1993) Amino acid polymorphism in insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 342:828–832PubMedCrossRefGoogle Scholar
  2. Arner P, Pollare T, Lithell H (1991) Different aetiologies of Type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects. Diabetologia 34:483–487PubMedCrossRefGoogle Scholar
  3. Bailey CJ, Flatt PR (1990) New antidiabetic drugs. Smith-Gordon, LondonGoogle Scholar
  4. Banerji MA, Lebovitz HE (1989) Insulin-sensitive and insulin-resistant variants in NIDDM. Diabetes 38:784–792PubMedCrossRefGoogle Scholar
  5. Barnett AH, Eff C, Leslie RDG, Pyke DA (1981) Diabetes in identical twins: a study of 200 pairs. Diabetologia 20:87–93PubMedCrossRefGoogle Scholar
  6. Baron AD, Kolterman OG, Bell J, Mandarino LJ, Olefsky JM (1985) Rates of noninsulin-mediated glucose uptake are elevated in type II diabetic subjects. J Clin Invest 76: 1782–1788PubMedCrossRefGoogle Scholar
  7. Beck-Nielsen H, Hother-Nielsen O (1988) Insulin resistance. Diabetes Ann 4: 565–591Google Scholar
  8. Beck-Nielsen H, Vaag A, Damsbo P, Handberg A, Hother Nielsen O, Henriksen JE, Thye-Ronn P (1992) Insulin resistance in skeletal muscles in patients with NIDDM. Diabetes Care 15:418–429PubMedCrossRefGoogle Scholar
  9. Bell GI (1991) Lilly lecture 1990. Molecular defects in diabetes mellitus. Diabetes 40:413–422PubMedCrossRefGoogle Scholar
  10. Bergman RN, Steil GM, Bradley DC, Watanabe RM (1992) Modeling of insulin action in vivo. Annu Rev Physiol 54:861–883PubMedCrossRefGoogle Scholar
  11. Björntorp P (1988) Abdominal obesity and the development of noninsulin-dependent diabetes mellitus. Diabetes Metab Rev 4:615–622PubMedCrossRefGoogle Scholar
  12. Björntorp P (1990) Obesity and diabetes. In: Alberti KGMM, Krall LP (eds) The diabetes annual/5. Elsevier, Amsterdam, pp 373–395Google Scholar
  13. Bogardus C, Lillioja A, Stone K, Mott D (1984) Correlation of muscle glycogen synthase activity and in vivo insulin action in man. J Clin Invest 73:1185–1190PubMedCrossRefGoogle Scholar
  14. Bonora E, Zavaroni I, Bruschi F, Alpi O, Pezzarossa A, Guerra L, Dall’Aglio E, Coscelli C, Butturini U (1984) Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism? J Clin Endocrinol Metab 59:1121–1127PubMedCrossRefGoogle Scholar
  15. Bray GA (1990) Obesity and diabetes. Acta Diabetol Lat 27:81–88PubMedCrossRefGoogle Scholar
  16. Bressler R, Johnson D (1992) New pharmacological approaches to therapy of NIDDM. Diabetes Care 15:792–805PubMedCrossRefGoogle Scholar
  17. Brunzell JD, Robertson RP, Lerner RL, Hazzard WR, Ensinck JW, Bierman EL, Porte D (1976) Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 46:222–229CrossRefGoogle Scholar
  18. Butler PC, Kryshak EJ, Schwenk WF, Haymond MW, Rizza RA (1990) Hepatic and extrahepatic responses to insulin in NIDDM and nondiabetic humans: assessment in absence of artifact introduced by tritiated nonglucose contaminants. Diabetes 39:217–225PubMedCrossRefGoogle Scholar
  19. Campbell PJ, Carlson MG (1993) Impact of obesity on insulin action in NIDDM. Diabetes 42:405–410PubMedCrossRefGoogle Scholar
  20. Campbell PJ, Mandarino LJ, Gerich JE (1988) Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. Metabolism 37:15–21PubMedCrossRefGoogle Scholar
  21. Capaldo B, Napoli R, Di Bonito P, Albano G, Sacca L (1990) Glucose and gluconeogenic substrate exchange by the forearm skeletal muscle in hyperglycemic and insulin-treated type II diabetic patients. J Clin Endocrinol Metab 71: 1220–1223PubMedCrossRefGoogle Scholar
  22. Caro JF, Dohm LG, Pories WJ, Sinha MK (1989) Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type 2 diabetes. Diabetes Metab Rev 5:665–689PubMedCrossRefGoogle Scholar
  23. Castillo MJ, Scheen AJ, Jandrain B, Lefèbvre PJ (1994a) Relationships between metabolic clearance rate of insulin and body mass index in a female population ranging from anorexia nervosa to severe obesity. Int J Obes 18:47–53Google Scholar
  24. Castillo MJ, Scheen AJ, Letiexhe MR, Lefèbvre PJ (1994b) How to measure insulin clearance. Diabetes Metab Rev 10:119–150PubMedCrossRefGoogle Scholar
  25. Cerasi E (1988) Insulin secretion in diabetes mellitus. In: Lefèbvre PJ, Pipeleers DG (eds) The pathology of the endocrine pancreas in diabetes. Springer, Berlin Heidelberg New York, pp 191–218CrossRefGoogle Scholar
  26. Clark A (1992) Islet amyloid: an enigma of type 2 diabetes. Diabetes Metab Rev 8:117–132PubMedCrossRefGoogle Scholar
  27. Consoli A (1992) Role of liver in pathophysiology of NIDDM. Diabetes Care 15:430–441PubMedCrossRefGoogle Scholar
  28. Consoli A, Nurjhan N, Capani F, Gerich J (1989) Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 38: 550–557PubMedCrossRefGoogle Scholar
  29. Consoli A, Nurjhan N, Reilly JJ Jr, Bier DM, Gerich JE (1990) Mechanism of increased gluconeogenesis in non-insulin dependent diabetes mellitus: role of alterations in systemic, hepatic and muscle lactate and alanine metabolism. J Clin Invest 86:2034–2045CrossRefGoogle Scholar
  30. Cox NJ, Xiang K-S, Fajans SS, Bell GI (1992) Mapping diabetes-susceptibility genes: lessons learned from search for DNA marker for maturity-onset-diabetes of the young. Diabetes 41:401–407PubMedCrossRefGoogle Scholar
  31. DeFronzo RA (1988) The triumvirate: B-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667–687PubMedGoogle Scholar
  32. DeFronzo RA, Ferrannini E (1987) Regulation of hepatic glucose metabolism in humans. Diabetes Metab Rev 3:415–459PubMedCrossRefGoogle Scholar
  33. DeFronzo RA, Ferrannini E (1991) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173–194PubMedCrossRefGoogle Scholar
  34. DeFronzo RA, Ferrannini E, Koivisto V (1983) New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus. Am J Med 75:52–81CrossRefGoogle Scholar
  35. DeFronzo R, Gunnarsson R, Bjorkman O, Olsson M, Wahren J (1985) Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin dependent (type II) diabetes mellitus. J Clin Invest 76:146–155CrossRefGoogle Scholar
  36. DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318–368PubMedCrossRefGoogle Scholar
  37. DelPrato S, Bonadonna RC, Bonora E, Guli G, Solini A, Shank M, DeFronzo RA (1993) Characterization of cellular defects of insulin action in type 2 (noninsulin-dependent) diabetes mellitus. J Clin Invest 91:484–494CrossRefGoogle Scholar
  38. Dinneen S, Gerich J, Rizza R (1992) Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 327:707–713PubMedCrossRefGoogle Scholar
  39. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L (1989) Early metabolic defects in persons at risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337–343PubMedCrossRefGoogle Scholar
  40. Eriksson J, Koranyi L, Bourey R, Schalin-Jantti C, Widen E, Mueckler M, Permutt AM, Groop LC (1992) Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle. Diabetologia 35:143–147PubMedCrossRefGoogle Scholar
  41. Eschwège E, Mehnert H, Reaven G, Vigneri R (eds) (1991) NIDD today. Diabete Metab 17:75–254Google Scholar
  42. Fajans SS (1986) Heterogeneity of insulin secretion in type II diabetes. Diabetes Metab Rev 2:347–361PubMedCrossRefGoogle Scholar
  43. Felber JP, Golay A, Felley C, Jéquier E (1988) Regulation of glucose storage in obesity and diabetes: metabolic aspects. Diabetes Metab Rev 4:691–700PubMedCrossRefGoogle Scholar
  44. Felber JP, Acheson KJ, Tappy L (1993a) From obesity to diabetes. Wiley, ChichesterGoogle Scholar
  45. Felber JP, Haesler E, Jéquier E (1993b) Metabolic origin of insulin resistance in obesity with and without Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36:1221–1229PubMedCrossRefGoogle Scholar
  46. Ferner RE, Alberti KGMM (1986) Why is there still disagreement over insulin secretion in non-insulin-dependent diabetes? Diabet Med 3:13–17PubMedCrossRefGoogle Scholar
  47. Ferrannini E, Cobelli C (1987) The kinetics of insulin in man. Diabetes Metab Rev 3:335–363, 365–397PubMedCrossRefGoogle Scholar
  48. Ferrannini E, Groop LC (1989) Hepatic glucose production in insulin-resistant states. Diabetes Metab Rev 5:711–725PubMedCrossRefGoogle Scholar
  49. Foley JE (1992) Rationale and application of fatty acid oxidation inhibitors in treatment of diabetes mellitus. Diabetes Care 15:773–784PubMedCrossRefGoogle Scholar
  50. Froguel Ph, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa Ph, Permutt MA, Beckmann JS, Bell GI, Cohen D (1993) Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 328:697–702PubMedCrossRefGoogle Scholar
  51. Ganrot PO (1993) Insulin resistance syndrome: possible key role of blood flow in resting muscle. Diabetologia 36:876–879PubMedCrossRefGoogle Scholar
  52. Garvey WT (1989) Insulin resistance and noninsulin-dependent diabetes mellitus: which horse is pulling the cart? Diabetes Metab Rev 5:727–742PubMedCrossRefGoogle Scholar
  53. Garvey WT (1992) Glucose transport and NIDDM. Diabetes Care 15:396–417PubMedCrossRefGoogle Scholar
  54. Garvey WT, Kolterman OG (1988) Correlation of in vivo and in vitro actions of insulin in obesity and noninsulin-dependent diabetes mellitus: role of the glucose transport system. Diabetes Metab Rev 4:543–569PubMedCrossRefGoogle Scholar
  55. Garvey TW, Revers RR, Kolterman OG, Rubenstein AH, Olefsky JM (1985) Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus. J Clin Endocrinol Metab 60:559–568PubMedCrossRefGoogle Scholar
  56. Gerich JE (1988) Role of insulin resistance in the pathogenesis of Type 2 (noninsulin-dependent) diabetes mellitus. Bailliere’s Clin Endocrinol Metab 2: 307–326CrossRefGoogle Scholar
  57. Gerich JE (1991) Is muscle the major site of insulin resistance in Type 2 (non-insulin-dependent) diabetes mellitus? Diabetologia 34:607–610PubMedCrossRefGoogle Scholar
  58. Gerich JE (1993) Control of glycaemia. Bailliere’s Clin Endocrinol Metab 7:551–586CrossRefGoogle Scholar
  59. Giugliano D, Torella R, Scheen AJ, Lefèbvre PJ, D’Onofrio F (1988) Prostaglandines, sécrétion d’insuline et diabète sucré. Diabete Metab 14:721–727PubMedGoogle Scholar
  60. Golay A, Felber JP, Jéquier E, DeFronzo RA, Ferrannini E (1988) Metabolic basis of obesity and noninsulin-dependent diabetes mellitus. Diabetes Metab Rev 4:727–747PubMedCrossRefGoogle Scholar
  61. Granner DK, O’Brien RM (1992) Molecular physiology and genetics of NIDDM. Importance of metabolic staging. Diabetes Care 15:369–395PubMedCrossRefGoogle Scholar
  62. Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, DeFronzo RA (1989) Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus: evidence for multiple sites of insulin resistance. J Clin Invest 84:205–213PubMedCrossRefGoogle Scholar
  63. Groop LC, Kankuri M, Schalin-Jantti C, Ekstrand A, Nikula-Ijas P, Widen E, Kuismanen E, Eriksson J, Franssila-Kallunki A, Saloranta C, Koskimies S (1993a) Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl Med 328:10–14CrossRefGoogle Scholar
  64. Groop LC, Widen E, Ferrannini E (1993b) Insulin resistance and insulin deficiency in the pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia 36:1326–1331PubMedCrossRefGoogle Scholar
  65. Haffner SM, Stern MP, Watanabe RN, Bergman RN (1992) Relationship of insulin clearance and secretion to insulin sensitivity in non-diabetic Mexican Americans. Eur J Clin Invest 22:147–153PubMedCrossRefGoogle Scholar
  66. Hales CN, Barker DJP (1992) Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis. Diabetologia 35:595–601PubMedCrossRefGoogle Scholar
  67. Hamman RF (1992) Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Metab Rev 8:287–338PubMedCrossRefGoogle Scholar
  68. Häring HU, Mehnert H (1993) Pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus: candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle. Diabetologia 36:176–182PubMedCrossRefGoogle Scholar
  69. Harris MI (1993) Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 16:642–655PubMedGoogle Scholar
  70. Hitman GA, McCarthy MI (1991) Genetics of non-insulin dependent diabetes mellitus. Bailliere’s Clin Endocrinol Metab 5:455–476CrossRefGoogle Scholar
  71. Hortulanus-Beck D, Lefèbvre PJ, Jeanjean MF (1990) Le diabète dans la province belge de Luxembourg: Fréquence, importance de l’épreuve de surcharge glucosée orale et d’une glycémie à jeun discrètement accrue. Diabete Metab 16:311–317PubMedGoogle Scholar
  72. Hother-Nielsen O, Beck-Nielsen H (1990) On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion. Diabetologia 33:603–610PubMedCrossRefGoogle Scholar
  73. Jansson P-AE, Fowelin JP, Von Schenck HP, Smith UP, Lönnroth PN (1993) Measurement by microdialysis of the insulin concentration in subcutaneous interstitial fluid. Importance of the endothelial barrier for insulin. Diabetes 42:1469–1473PubMedCrossRefGoogle Scholar
  74. Johnson KH, O’Brien TD, Betsholtz C, Westermark P (1989) Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus. N Engl J Med 321:513–518PubMedCrossRefGoogle Scholar
  75. Kahn CR (1978) In:sulin resistance, insulin sensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism 27:1893–1902PubMedCrossRefGoogle Scholar
  76. Kahn CR, Folli F (1993) Molecular determinants of insulin action. Horm Res [Suppl 3]:93–101CrossRefGoogle Scholar
  77. Karam JH, Grodsky GM, Forsham PH (1963) Excessive insulin response to glucose in obese subjects as measured by immunochemical assay. Diabetes 12:197–204PubMedGoogle Scholar
  78. Kelley DE, Mokan M, Mandarino LJ (1992) Intracellular defects in glucose metabolism in obese patients with NIDDM. Diabetes 41:698–706PubMedCrossRefGoogle Scholar
  79. Kelley DE, Mokan M, Mandarino LJ (1993) Metabolic pathways of glucose in skeletal muscle of lean NIDDM. Diabetes Care 16:1158–1166PubMedCrossRefGoogle Scholar
  80. King GL, Johnson SM (1985) Receptor-mediated transport of insulin across endothelial cells. Science 227:1583–1586PubMedCrossRefGoogle Scholar
  81. King H, Rewers M, WHO Ad Hoc Diabetes Reporting Group (1993) Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance. Diabetes Care 16:157–177PubMedCrossRefGoogle Scholar
  82. Kissebah AH, Peiris AN (1989) Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 5:83–109PubMedCrossRefGoogle Scholar
  83. Klip A, Paquet MR (1990) Glucose transport and glucose transporters in muscle and their metabolic regulation. Diabetes Care 13:228–243PubMedCrossRefGoogle Scholar
  84. Kolterman O, Gray R, Griffin J, Burstein P, Insel J, Scarlett J, Olefsky J (1981) Receptor and postreceptor defects contribute to the insulin resistance of noninsulin-dependent diabetes mellitus. J Clin Invest 68:957–969PubMedCrossRefGoogle Scholar
  85. Kriska AM, Bennett PH (1991) An epidemiological perspective of the relationship between physical activity and NIDDM: from activity assessment to intervention. Diabetes Metab Rev 8:355–372CrossRefGoogle Scholar
  86. Kusari J, Verma US, Buse JB, Henry RR, Olefsky JM (1991) Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus. J Clin Invest 88:1323–1330PubMedCrossRefGoogle Scholar
  87. Laakso M, Edelman SV, Hoit B, Brechtel G, Baron AD (1992) Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 41: 1076–1083PubMedCrossRefGoogle Scholar
  88. Leahy JL (1990) Natural history of B-cell dysfunction in NIDDM. Diabetes Care 13:992–1010PubMedCrossRefGoogle Scholar
  89. Leahy JL, Bonner-Weir S, Weir GC (1992) B-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care 15:442–455PubMedCrossRefGoogle Scholar
  90. Lefèbvre PJ (1991) Diabetes. Abnormal secretion of glucagon. In: Samols E (ed) The endocrine pancreas. Raven, New York, pp 191–205Google Scholar
  91. Lefèbvre PJ (1993) Syndrome X. Diab Nutr Metab 6:61–65Google Scholar
  92. Lefèbvre PJ, Scheen AJ (1992) Management of non-insulin-dependent diabetes mellitus. Drugs 44 [Suppl 3]:29–38PubMedCrossRefGoogle Scholar
  93. Lefèbvre PJ, Paolisso G, Scheen AJ, Henquin JC (1987) Pulsatility of insulin and glucagon release: Physiological significance and pharmacological implications. Diabetologia 30:443–452PubMedCrossRefGoogle Scholar
  94. Lefèbvre PJ, Paolisso G, Scheen A (1991) The role of glucagon in non-insulin-dependent (type 2) diabetes mellitus. In: Sakamoto N, Angel A, Hotta H (eds) New directions in research and clinical works for obesity and diabetes mellitus. Excerpta Medica, Amsterdam, pp 25–29Google Scholar
  95. Lefèbvre PJ, Scheen AJ, Paolisso G, Giugliano D (1992) Opioid peptides and carbohydrate metabolism. In: Negri M, Lotti G, Grossman A (eds) Clinical perspectives of endogenous opioids production. Wiley, London, pp 255–273Google Scholar
  96. Lefèbvre PJ, Paolisso G, Scheen AJ (1994) Magnésium et métabolisme glucidique. Thérapie 49:1–7PubMedGoogle Scholar
  97. Lillioja S, Young AA, Cutler CL, Ivy JL, Abbott GH, Zawadzki JK, Yki-Jarvinen H, Christin L, Secomb TW, Bogardus C (1987) Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 80:415–424PubMedCrossRefGoogle Scholar
  98. Lillioja S, Bogardus C (1988) Obesity and insulin resistance: lessons learned from the Pima indians. Diabetes Metab Rev 4:517–540PubMedCrossRefGoogle Scholar
  99. Malaisse WJ (1988) Possible sites for deficient glucose recognition in islet cells. In: Lefèbvre PJ, Pipeleers DG (eds) The pathology of the endocrine pancreas in diabetes. Springer, Berlin Heidelberg New York, pp 219–232CrossRefGoogle Scholar
  100. Mandarino LJ (1989) Regulation of skeletal muscle pyruvate dehydrogenase and glycogen synthase in man. Diabetes Metab Rev 5:475–486PubMedCrossRefGoogle Scholar
  101. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925–929PubMedCrossRefGoogle Scholar
  102. Matschinsky FM (1990) Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes 39:647–652PubMedCrossRefGoogle Scholar
  103. Matschinsky F, Liang Y, Kesavan P, Wang L, Froguel Ph, Velho G, Cohen D, Permutt MA, Tanizawa Y, Jetton TL, Niswender K, Magnuson MA (1993) Glucokinase as pancreatic B cell glucose sensor and diabetes gene. J Clin Invest 92:2092–2098PubMedCrossRefGoogle Scholar
  104. Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J (1992) Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326:22–29PubMedCrossRefGoogle Scholar
  105. Moller DE (1993) Insulin resistance. Wiley, ChichesterGoogle Scholar
  106. Moller DE, Flier JS (1991) Insulin resistance. Mechanisms, syndromes, and implications. N Engl J Med 325:938–948PubMedCrossRefGoogle Scholar
  107. O’Dea K (1992) Obesity and diabetes in “the land of milk and honey” . Diabetes Metab Rev 8:373–388PubMedCrossRefGoogle Scholar
  108. Olefsky JM (1976) The insulin receptor: its role in insulin resistance in obesity and diabetes. Diabetes 25:1154–1165PubMedGoogle Scholar
  109. Olefsky JM, Garvey WT, Henry RR, Brillon D, Matthaei S, Freidenberg GR (1988) Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes. Am J Med 85 [Suppl 5A]: 86–105PubMedCrossRefGoogle Scholar
  110. O’Rahilly SP, Nugent Z, Rudenski AS, Hosker JP, Burnett MA, Darling P, Turner RC (1986) Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes. Lancet II: 360–363CrossRefGoogle Scholar
  111. O’Rahilly S, Turner RC, Matthews DR (1988) Impaired pulsatile secretion of insulin in relatives of patients with non-insulin dependent diabetes. N Engl J Med 318:1225–1230PubMedCrossRefGoogle Scholar
  112. Paolisso G, Sgambato S, Giugliano D, Torella R, Varricchio M, Scheen AJ, D’Onofrio F, Lefèbvre PJ (1988) Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31:910–915PubMedCrossRefGoogle Scholar
  113. Paolisso G, Scheen AJ, D’Onofrio F, Lefèbvre PJ (1990) Magnesium and glucose homeostasis. Diabetologia 33:511–514PubMedCrossRefGoogle Scholar
  114. Pedersen O (1989) The impact of obesity on the pathogenesis of non-insulin-dependent diabetes mellitus: a review of current hypotheses. Diabetes Metab Rev 5:495–509PubMedCrossRefGoogle Scholar
  115. Permutt MA, Elbein SC (1990) Insulin gene in diabetes: analysis through RFLP. Diabetes Care 13:364–372PubMedCrossRefGoogle Scholar
  116. Permutt MA, Chiu KC, Tanizawa Y (1992) Glucokinase and NIDDM: a candidate gene that paid off. Diabetes 41:1367–1372PubMedCrossRefGoogle Scholar
  117. Polonsky K, Frank B, Pugh W, Addis A, Karrison T, Meier P, Tager H, Rubenstein A (1986a) The limitations to and valid use of C-peptide as a marker of the secretion of insulin. Diabetes 35:379–386PubMedCrossRefGoogle Scholar
  118. Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, Karrison T, Frank B (1986b) Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest 77:98–105PubMedCrossRefGoogle Scholar
  119. Polonsky KS, Given BD, Hirsch L, Shapiro EJ, Tillil H, Beebe C, Galloway JA, Frank BH, Karrison T, Van Cauter E (1988a) Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 81:435–441PubMedCrossRefGoogle Scholar
  120. Polonsky KS, Given BD, Hirsch LJ, Tillil H, Shapiro ET (1988b) Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med 318:1231–1239PubMedCrossRefGoogle Scholar
  121. Porte D Jr (1991) B-cells in type II diabetes mellitus. Diabetes 40:166–180PubMedCrossRefGoogle Scholar
  122. Porte D Jr, Kahn SE (1989) Hyperproinsulinemia and amyloid in NIDDM — clues to etiology of islet B-cell dysfunction? Diabetes 38:1333–1336PubMedCrossRefGoogle Scholar
  123. Rahier J(1988) The diabetic pancreas: a pathologist’s view. In: Lefèbvre PJ, Pipeleers DG (eds) The pathology of the endocrine pancreas in diabetes. Springer, Berlin Heidelberg New York, pp 17–40CrossRefGoogle Scholar
  124. Randle PJ (1993) Glucokinase and candidate genes for Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36:269–275PubMedCrossRefGoogle Scholar
  125. Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785–789PubMedCrossRefGoogle Scholar
  126. Rasmussen H, Zawalich KC, Ganesan S, Calle R, Zawalich WS (1990) Physiology and pathophysiology of insulin secretion. Diabetes Care 13:655–666PubMedCrossRefGoogle Scholar
  127. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37:1595–1607PubMedCrossRefGoogle Scholar
  128. Reaven GM (1990) Non-insulin-dependent diabetes (NIDDM): speculations on etiology. In Alberti KGMM, Krall LP (eds) The diabetes annual/5. Elsevier, Amsterdam, pp 51–71Google Scholar
  129. Robertson RP (1989) Type II diabetes, glucose “non-sense”, and islet desensitization. Diabetes 38:1501–1505PubMedCrossRefGoogle Scholar
  130. Rossetti L, Giaccari A, DeFronzo RA (1990) Glucose toxicity. Diabetes Care 13:610–630.PubMedCrossRefGoogle Scholar
  131. Rudenski AS, Matthews DR, Levy JC, Turner RC (1991) Understanding “insulin resistance”: both glucose resistance and insulin resistance are required to model human diabetes. Metabolism 40:908–917PubMedCrossRefGoogle Scholar
  132. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Charles MA, Bennett PH (1991) A two-step model for development of non-insulin-dependent diabetes. Am J Med 90:229–235PubMedGoogle Scholar
  133. Saltiel AR (1990) Second messengers of insulin action. Diabetes Care 13:244–256PubMedCrossRefGoogle Scholar
  134. Schalin-Jantti C, Harkonen M, Groop LC (1992) Impaired activation of glycogen synthase activity in skeletal muscle from obese patients with and without Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34:239–245Google Scholar
  135. Scheen AJ (1992) From obesity to type 2 diabetes. Acta Clin Belg 47 [Suppl 14]: 30–36Google Scholar
  136. Scheen AJ, Lefèbvre PJ (1992) Assessment of insulin sensitivity in vivo. Application to the study of type 2 diabetes. Horm Res 38:19–27PubMedCrossRefGoogle Scholar
  137. Scheen AJ, Lefèbvre PJ (1993a) De l’obésité au diabète ou de l’insulino-résistance au déficit insulino-sécrétoire. Rev Franç Endocrinol Clin 34:297–310Google Scholar
  138. Scheen AJ, Lefèbvre PJ (1993b) Pharmacological treatment for the obese diabetic patient. Diabete Metab 19:547–559PubMedGoogle Scholar
  139. Scheen AJ, Nemery A, Luyckx AS, Lefèbvre PJ (1986) Etiologie et Physiopathologie des diabètes sucrés. Encycl Méd Chir. Paris, Glandes-Nutrition, 10366 C10Google Scholar
  140. Scheen AJ, Paquot N, Lefèbvre PJ (1991) La cellule B dans le diabète de type II: coupable ou victime? In: Journées Annuelles de Diabétologie de l’Hôtel-Dieu. Flammarion Médecine-Sciences, Paris, pp 153–169Google Scholar
  141. Scheen AJ, Castillo M, Paolisso G, Jandrain B, Lefèbvre PJ (1992a) Normal feedback inhibition of insulin secretion by insulin but reduced metabolic clearance rate of the hormone in obese subjects. In: Ailhaud G, Guy-Grand B, Lafontan M, Ricquier D (eds) Obesity in Europe 91. Libbey, London, pp 201–205Google Scholar
  142. Scheen AJ, Paolisso G, Castillo M, Jandrain B, Paquot N, Lefèbvre PJ (1992b) Insulin secretion and action in various populations with type 2 (non-insulin-dependent) diabetes mellitus (Abstract). Diabetologia 35 [Suppl 1]: A87Google Scholar
  143. Scheen AJ, Paquot N, Castillo MJ, Lefèbvre PJ (1994) How to measure insulin action. Diabetes Metab Rev 10:151–188PubMedCrossRefGoogle Scholar
  144. Serjeantson SW, Zimmet P (1991) Genetics of non-insulin dependent diabetes mellitus in 1990. Bailliere’s Clin Endocrinol Metab 5:477–493CrossRefGoogle Scholar
  145. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG (1990) Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223–228PubMedCrossRefGoogle Scholar
  146. Songer TJ (1992) The economic costs of NIDDM. Diabetes Metab Rev 8:389–404PubMedCrossRefGoogle Scholar
  147. Steiner DF, Tager HS, Chan SJ, Nanjo T, Sanke T, Rubenstein AH (1990) Lessons learned from molecular biology of insulin-gene mutations. Diabetes Care 13: 600–607PubMedCrossRefGoogle Scholar
  148. Sturis J, Polonsky KS, Shapiro ET, Blackman JD, O’Meara NM, Van Cauter E (1992) Abnormalities in the ultradian oscillations of insulin secretion and glucose levels in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 35:681–689PubMedCrossRefGoogle Scholar
  149. Temple RC, Clark PMS, Nagi DK, Schneider AE, Yudkin JS, Hales CN (1990) Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics. Clin Endocrinol (Oxf) 32:689–693CrossRefGoogle Scholar
  150. Temple RC, Clark PMS, Hales CN (1992) Measurement of insulin secretion in type 2 diabetes: problems and pitfalls. Diabetic Med 9:503–512PubMedCrossRefGoogle Scholar
  151. Thorens B, Waeber G (1993) Glucagon-like peptide-1 and the control of insulin secretion in the normal state and in NIDDM. Diabetes 42:1219–1225PubMedCrossRefGoogle Scholar
  152. Thornburn AW, Gumbiner B, Bulacan F, Brechtel G, Henry RR (1991) Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus. J Clin Invest 87:489–495CrossRefGoogle Scholar
  153. Turner RC, Matthews DR, Clark A, O’Rahilly S, Rudenski AS, Levy J (1988) Pathogenesis of NIDDM — a disease of deficient insulin secretion. Bailliere’s Clin Endocrinol Metab 2:327–342CrossRefGoogle Scholar
  154. Unger RH (1991) Diabetic hyperglycemia: link to impaired glucose transport in pancreatic B-cells. Science 251:1200–1205PubMedCrossRefGoogle Scholar
  155. Unger RH, Grundy S (1985) Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 28:119–121PubMedCrossRefGoogle Scholar
  156. Vaag A, Henriksen JE, Beck-Nielsen H (1992) Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 89:782–788PubMedCrossRefGoogle Scholar
  157. Vadheim CM, Rotter JI (1992) Genetics of diabetes mellitus. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P (eds) International textbook of diabetes mellitus. Wiley, Chichester, pp 31–98Google Scholar
  158. Vague J, Vague Ph (1988) Obesity and diabetes. In: Alberti KGMM, Krall LP (eds) The diabetes annual/4. Elsevier Science, Amsterdam, pp 311–338Google Scholar
  159. Velho G, Froguel Ph, Clément K, Pueyo ME, Rakotoambinina B, Zouali H, Passa Ph, Cohen D, Robert JJ (1992) Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet 340:444–448PubMedCrossRefGoogle Scholar
  160. Vestergaard H, Bjorbaek C, Andersen PH, Bak JF, Pedersen O (1991) Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients. Diabetes 40:1740–1745PubMedCrossRefGoogle Scholar
  161. Ward WK, Beard JC, Porte D Jr (1986) Clinical aspects of islet B-cell function in non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 2:297–313PubMedCrossRefGoogle Scholar
  162. Westermark P, Johnson KH, O’Brien TD, Betsholtz C (1992) Islet amyloid polypeptide — a novel controversy in diabetes research. Diabetologia 35:297–303PubMedCrossRefGoogle Scholar
  163. Wolffenbuttel BHR, Van Haeften TW (1993) Non-insulin dependent diabetes mellitus: defects in insulin secretion. Eur J Clin Invest 23:69–79PubMedCrossRefGoogle Scholar
  164. Yalow RS, Berson SA (1960) Plasma insulin concentrations in nondiabetic and early diabetic subjects. Determination by a new sensitive immunoasssay technique. Diabetes 9:254–260PubMedGoogle Scholar
  165. Yki-Järvinen H (1992) Glucose toxicity. Endocr Metab Rev 15:415–431Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • A. J. Scheen
  • P. J. Lefèbvre

There are no affiliations available

Personalised recommendations